S. H. Kim et al. / Tetrahedron Letters 50 (2009) 5744–5747
5747
Ruchirawat, S. J. Org. Chem. 2007, 72, 9379–9382; (b) Su, S.; Porco, J. A., Jr. J. Am.
Chem. Soc. 2007, 129, 7744–7745; (c) Dhawan, R.; Arndtsen, B. A. J. Am. Chem.
Soc. 2004, 126, 468–469; (d) Pandey, P. S.; Rao, T. S. Bioorg. Med. Chem. Lett. 2004,
14, 129–131.
126.38, 126.65, 128.28, 128.31, 134.35, 134.71, 137.47, 166.24; ESIMS m/z 268
[M+H]+. Anal. Calcd for C17H17NO2: C, 76.38; H, 6.41; N, 5.24. Found: C, 76.12; H,
6.65; N, 5.11.
Compound 2g: 52%; pale yellow oil; IR (film) 3304, 1676, 1465 cmÀ1 1H NMR
;
7. Prepared starting materials were identified by their IR, 1H NMR, and mass data.8
Compounds 1i and 1j were prepared according to the references, see: (a) Lev, I.
J.; Ishikawa, K.; Bhacca, N. S.; Griffin, G. W. J. Org. Chem. 1976, 41, 2654–2656; (b)
Sakai, T.; Amano, E.; Kawabata, A.; Takeda, A. J. Org. Chem. 1980, 45, 43–47.
8. Typical procedure for the synthesis of compounds 2a and 3a: A mixture of desyl
chloride (346 mg, 1.5 mmol), methyl cyanoacetate (297 mg, 3.0 mmol), and
K2CO3 (276 mg, 2.0 mmol) in DMF (3 mL) was stirred at room temperature for
2 h. After the usual aqueous workup and column chromatographic purification
process (hexanes/EtOAc, 8:1), compound 1a was obtained as colorless oil,
330 mg (75%) as a syn/anti mixture (3:1). A stirred mixture of compound 1a
(293 mg, 1.0 mmol), allyl bromide (242 mg, 2.0 mmol), and indium (115 mg,
1.0 mmol) in THF (1.5 mL) was heated to reflux for 30 min. After the usual
aqueous workup and column chromatographic purification process (hexanes/
CH2Cl2/EtOAc, 16:1:1), we obtained compound 2a (175 mg, 55%) and compound
3a (10 mg, 3%). Other compounds were synthesized similarly and the
spectroscopic data of 1a, 2a, 2f, 2g, 3a, 3j, and 4 are as follows.
(CDCl3, 300 MHz) d 3.63 (s, 3H), 3.80 (dt, J = 6.9 and 1.2 Hz, 2H), 4.21 (s, 2H),
5.19–5.26 (m, 2H), 5.94–6.07 (m, 1H), 7.10–7.14 (m, 3H), 7.20–7.36 (m, 7H), 8.31
(br s, 1H); 13C NMR (CDCl3, 75 MHz) d 31.21, 32.17, 50.36, 111.56, 118.07,
119.98, 125.24, 127.09, 127.23, 127.90, 128.04, 128.77, 129.16, 132.34, 134.27,
137.23, 142.50, 165.93; ESIMS m/z 332 [M+H]+.
Compound 3a (major/minor, 1:1): 3%; pale yellow oil; IR (film) 3466, 3411, 3326,
1694, 1625, 1556, 1239 cmÀ1 1H NMR (CDCl3, 300 MHz)
; d 2.16–2.18 (m,
2H * 0.5), 2.41–2.92 (m, 6H * 0.5), 4.20 (s, 1H * 0.5), 4.28 (s, 1H * 0.5), 4.66–5.81
(m, 12H * 0.5), 6.81–7.07 (m, 8H * 0.5), 7.25–7.45 (m, 12H * 0.5); 13C NMR
(CDCl3, 75 MHz) d 37.37, 37.40, 43.52, 47.76, 55.07, 57.17, 87.49, 88.82, 92.22,
94.51, 117.92, 118.87, 119.97, 120.19, 124.95, 126.13, 126.27, 127.00, 127.23,
127.43, 127.72, 128.31, 128.69, 128.86, 130.95, 131.14, 132.40, 132.87, 140.09,
141.08, 141.84, 145.83, 157.84, 158.10, 172.90, 173.29, and two carbon peaks
were overlapped; ESIMS m/z 346 [M+H]+.
Compound 3j: 53%; colorless oil; IR (film) 3424, 3330, 1693, 1630, 1565,
1227 cmÀ1 1H NMR (DMSO-d6, 600 MHz) d 1.08–1.53 (m, 5H), 1.73–1.79 (m,
;
Compound 1a (major/minor, 3:1): 75%; colorless oil; IR (film) 2252, 1749, 1682,
2H), 1.84–1.85 (m, 1H), 2.13–2.19 (m, 1H), 2.24–2.28 (m, 1H), 2.65 (dd, J = 8.4
and 6.0 Hz, 1H), 2.86 (dd, J = 14.4 and 6.0 Hz, 1H), 2.93 (dd, J = 14.4 and 6.6 Hz,
1H), 5.03–5.19 (m, 4H), 5.70–5.77 (m, 1H), 5.81–5.88 (m, 1H), 6.65 (br s, 1H),
7.35 (br s, 1H); 13C NMR (CDCl3, 75 MHz) d 19.25, 20.48, 29.45, 30.51, 37.10,
40.72, 45.68, 83.25, 96.63, 118.47, 119.39, 132.30, 132.92, 154.59, 173.44; ESIMS
m/z 248 [M+H]+. Anal. Calcd for C15H21NO2: C, 72.84; H, 8.56; N, 5.66. Found: C,
72.89; H, 8.77; N, 5.48.
1449, 1266 cmÀ1 1H NMR (CDCl3, 300 MHz) d 3.72 (minor, s, 3H), 3.81 (major, s,
;
3H), 4.06 (minor, d, J = 7.2 Hz, 1H), 4.56 (major, d, J = 10.2 Hz, 1H), 5.20 (major, d,
J = 10.2 Hz, 1H), 5.30 (minor, d, J = 7.2 Hz, 1H), 7.27–7.41 (major and minor, m,
14H), 7.46–7.53 (major and minor, m, 2H), 7.88–7.95 (major and minor, m, 4H);
ESIMS m/z 294 [M+H]+. Anal. Calcd for C18H15NO3: C, 73.71; H, 5.15; N, 4.78.
Found: C, 73.98; H, 5.37; N, 4.66.
Compound 2a: 55%; pale yellow solid, mp 135–136 °C; IR (KBr) 3302, 1681,
Compound 4: 88%; pale yellow solid, mp 208–210 °C; IR (KBr) 3324, 1713, 1466,
1460 cmÀ1
;
1H NMR (CDCl3, 300 MHz) d 3.60 (s, 3H), 3.82 (dt, J = 6.6 and 1.2 Hz,
1314, 1180 cmÀ1 1H NMR (CDCl3, 300 MHz) d 3.97 (s, 3H), 4.08 (dt, J = 6.6 and
;
2H), 5.22–5.31 (m, 2H), 5.97–6.11 (m, 1H), 7.06–7.31 (m, 10H), 8.39 (br s, 1H);
13C NMR (CDCl3, 75 MHz) d 32.09, 50.53, 111.92, 118.26, 123.58, 126.38, 126.65,
126.88, 127.59, 127.89, 128.44, 130.68, 132.06, 134.20, 135.67, 136.58, 165.78;
ESIMS m/z 318 [M+H]+. Anal. Calcd for C21H19NO2: C, 79.47; H, 6.03; N, 4.41.
Found: C, 79.54; H, 6.25; N, 4.31.
1.2 Hz, 2H), 5.30–5.37 (m, 2H), 6.04–6.17 (m, 1H), 7.43–7.48 (m, 1H), 7.52–7.57
(m, 1H), 7.64 (d, J = 9.0 Hz, 1H), 7.93–7.99 (m, 2H), 8.23 (d, J = 9.0 Hz, 1H), 8.99
(br s, 1H); 13C NMR (CDCl3, 75 MHz) d 32.27, 50.93, 109.72, 118.75, 119.09,
120.87, 121.02, 122.45, 123.53, 124.29, 125.77, 128.93, 129.10, 130.43, 133.80,
142.33, 166.24; ESIMS m/z 266 [M+H]+. Anal. Calcd for C17H15NO2: C, 76.96; H,
5.70; N, 5.28. Found: C, 77.07; H, 5.71; N, 5.09.
Compound 2f: 62%; pale yellow oil; IR (film) 3304, 1672, 1467 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 2.89–3.03 (m, 4H), 3.80–3.82 (m, 2H), 3.82 (s, 3H), 5.18–5.26
(m, 2H), 5.93–6.07 (m, 1H), 7.04–7.20 (m, 4H), 8.46 (br s, 1H); 13C NMR (CDCl3,
75 MHz) d 21.46, 29.46, 32.04, 50.65, 110.18, 117.94, 118.07, 121.82, 125.55,
9. For the similar enaminobutyrolactones, see: (a) Duron, S. G.; Gin, D. Y. Org. Lett.
2001, 3, 1551–1554; (b) Bower, J. F.; Szeto, P.; Gallagher, T. Org. Lett. 2007, 9,
4909–4912.